Key facts
- This page summarizes Shameek Konar's Form 4 filing for Comera Life Sciences Holdings, Inc..
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 02 Feb 2024, 19:48.
Shameek Konar - 29 Dec 2023 Form 4 Insider Report for Comera Life Sciences Holdings, Inc.
- Reporting relationship
- Member of 10% owner group
- Issuer ticker
- N/A
- Reported as of
- 29 Dec 2023
- Net transaction value
- +$112,500
- SEC form
- 4
- Accepted by SEC
- 02 Feb 2024, 19:48:13 UTC
- Prior SEC filing
- 02 Feb 2024
- Next SEC filing
- 28 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Shameek Konar
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Shameek Konar filed Form 4 for Comera Life Sciences Holdings, Inc. on 02 Feb 2024.
Change
- Previous filing in this sequence was filed on 02 Feb 2024.
- Current net transaction value: +$112,500.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CMRA
transaction
Derivative
12.0% Senior Secured Convertible Notes
Purchase
- Transaction value
- $112,500
- Shares
- Change %
- Price
- Shares after
- $112,500
- Date
- 29 Dec 2023
- Ownership
- By Regolith Capital Investments L.P.
- Underlying class
- Common Stock
- Underlying amount
- 2,045,454
- Exercise price
- $0.0550
- Footnotes
- F1, F2
CMRA
transaction
Derivative
Warrants to Purchase Common Stock
Purchase
- Transaction value
- $0
- Shares
- +4,090,908
- Change %
- Price
- $0.000000
- Shares after
- 4,090,908
- Date
- 29 Dec 2023
- Ownership
- By Regolith Capital Investments L.P.
- Underlying class
- Common Stock
- Underlying amount
- 4,090,908
- Exercise price
- $0.0550
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Regolith Capital Investments, L.P. ("Regolith") entered into a Securities Purchase Agreement with the Issuer on December 29, 2023, pursuant to which Regolith acquired (i) $112,500 principal amount of the Issuer's 12.0% Senior Secured Convertible Notes (the "Notes") and (ii) 4,090,908 warrants, each exercisable to purchase one share of the Company's common stock, par value $0.0001 per share ("Common Stock"), at an exercise price of $0.055 per share (the "Warrants"), representing 200% of the number of shares of Common Stock issuable upon conversion of the Notes immediately after the issuance thereof.
Footnote F2
The reporting persons are general partners of Regolith and disclaim beneficial ownership of the securities held by Regolith except to the extent of their pecuniary interest therein